BERARDICURTI, ONORINA
 Distribuzione geografica
Continente #
NA - Nord America 2.105
AS - Asia 1.003
EU - Europa 975
SA - Sud America 121
AF - Africa 20
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.227
Nazione #
US - Stati Uniti d'America 2.060
SG - Singapore 475
RU - Federazione Russa 308
IE - Irlanda 196
CN - Cina 183
VN - Vietnam 112
IT - Italia 110
HK - Hong Kong 108
BR - Brasile 102
DE - Germania 89
SE - Svezia 61
GB - Regno Unito 49
FR - Francia 45
TR - Turchia 38
UA - Ucraina 37
FI - Finlandia 30
CA - Canada 25
BD - Bangladesh 23
IN - India 18
MX - Messico 9
NL - Olanda 9
AR - Argentina 8
PL - Polonia 8
ZA - Sudafrica 7
BE - Belgio 6
CZ - Repubblica Ceca 6
ES - Italia 6
AT - Austria 5
JP - Giappone 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
IQ - Iraq 4
JO - Giordania 4
LB - Libano 4
SN - Senegal 4
DZ - Algeria 3
ID - Indonesia 3
KR - Corea 3
LT - Lituania 3
PH - Filippine 3
PY - Paraguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
EC - Ecuador 2
HR - Croazia 2
JM - Giamaica 2
KW - Kuwait 2
NP - Nepal 2
PK - Pakistan 2
SA - Arabia Saudita 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RO - Romania 1
TT - Trinidad e Tobago 1
Totale 4.227
Città #
Dallas 326
Chandler 285
Singapore 271
San Jose 198
Dublin 196
Ashburn 173
Jacksonville 157
Hong Kong 107
Santa Clara 82
Council Bluffs 69
New York 64
Boardman 59
The Dalles 50
Moscow 42
Los Angeles 35
Ho Chi Minh City 34
Beijing 32
L'aquila 30
Lawrence 28
Princeton 28
Wilmington 26
Izmir 21
Nanjing 21
Hanoi 19
Munich 19
L’Aquila 16
Lauterbourg 15
Orem 15
San Mateo 15
Hefei 14
Rome 14
Helsinki 13
São Paulo 12
Ann Arbor 11
Dearborn 10
Des Moines 10
Falkenstein 10
Montreal 10
Seattle 10
Shanghai 10
Woodbridge 10
Columbus 9
Kitzingen 9
Stockholm 9
Washington 9
Assago 8
Mountain View 8
Chicago 7
Frankfurt am Main 7
Milan 7
Warsaw 7
Brno 6
Brussels 6
Dong Ket 6
Johannesburg 6
London 6
Nanchang 6
Brooklyn 5
Chennai 5
Da Nang 5
Denver 5
Houston 5
Lappeenranta 5
Manchester 5
Ningbo 5
Paris 5
Poplar 5
Shenyang 5
Tokyo 5
Amman 4
Amsterdam 4
Brasília 4
Dakar 4
Hangzhou 4
Jiaxing 4
Mexico City 4
Nuremberg 4
Pune 4
Vienna 4
Ankara 3
Atlanta 3
Belo Horizonte 3
Boston 3
Bremen 3
Düsseldorf 3
Edinburgh 3
Grafing 3
Haiphong 3
Hebei 3
Hải Dương 3
Kunming 3
Norwalk 3
Phoenix 3
Piscataway 3
Rio de Janeiro 3
San Francisco 3
Seoul 3
São José dos Campos 3
Toronto 3
Turku 3
Totale 2.846
Nome #
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 181
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 174
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 155
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 154
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 150
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 143
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 141
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 138
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 137
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 132
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 132
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 126
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 125
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 124
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 123
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 119
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 117
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 117
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 117
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 117
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 114
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 114
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 110
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 109
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 109
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational "real-life" study 108
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 108
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 107
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 106
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry 103
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 100
The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection 99
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 90
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 90
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 87
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives 38
Totale 4.314
Categoria #
all - tutte 18.154
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.154


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/2022163 5 5 24 9 2 4 0 5 11 22 15 61
2022/2023666 57 54 17 96 37 73 0 39 249 3 27 14
2023/2024214 30 4 14 11 19 66 1 15 3 5 16 30
2024/2025810 33 13 51 52 105 66 97 58 163 63 55 54
2025/20261.886 112 172 235 195 181 116 261 45 143 273 132 21
Totale 4.314